Therapeutic effect of ansamitocin targeted to tumor by a bispecific monoclonal antibody.

Bispecific monoclonal antibody regulation of Fc gamma RIII-directed tumor cytotoxicity by large granular lymphocytes.

Regulatory T cells are redirected to kill glioblastoma by an EGFRvIII-targeted bispecific antibody.

Targeted Fcγ Receptor (FcγR)-mediated Clearance by a Biparatopic Bispecific Antibody.

Reversing EGFR Mediated Immunoescape by Targeted Monoclonal Antibody Therapy.

Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.

CD3 bispecific antibody.

Enhancement of tumor uptake and therapeutic efficacy of EGFR-targeted antibody cetuximab and antibody-drug conjugates by cholesterol sequestration.

Simultaneous blockade of VEGF and Dll4 by HD105, a bispecific antibody, inhibits tumor progression and angiogenesis.

Murine monoclonal anti-idiotype antibody (alpha) as a probe to detect human monoclonal antibody bound to human tumor tissues.

Therapeutic effect of a TM4SF5-specific monoclonal antibody against colon cancer in a mouse model.

In Situ immunization by bispecific antibody targeted T cell therapy in breast cancer.

Assessment of tumor cell kinetics by monoclonal antibody Ki-67.

Biodistribution Analyses of a Near-Infrared, Fluorescently Labeled, Bispecific Monoclonal Antibody Using Optical Imaging.

Targeted therapy of solid tumors by monoclonal antibody specific to epidermal growth factor receptor.

A human hybrid hybridoma producing a bispecific monoclonal antibody that can target tumor cells for attack by Pseudomonas aeruginosa exotoxin A.

Monoclonal antibody-targeted, temperature-sensitive liposomes: in vivo tumor chemotherapeutics in combination with mild hyperthermia.

A Murine, Bispecific Monoclonal Antibody Simultaneously Recognizing β-Glucan and MP65 Determinants in Candida Species.

Inhibition of human renal cancer by monoclonal antibody targeted methotrexate-containing liposomes in an ascites tumor model.

Therapeutic evaluation of monoclonal antibody-maytansinoid conjugate as a model of RON-targeted drug delivery for pancreatic cancer treatment.

A multifunctional bispecific antibody against Pseudomonas aeruginosa as a potential therapeutic strategy.

Effect of tumor size on monoclonal antibody uptake in a metastatic model.

Affinity Maturation of Monoclonal Antibody 1E11 by Targeted Randomization in CDR3 Regions Optimizes Therapeutic Antibody Targeting of HER2-Positive Gastric Cancer.

Monitoring therapeutic monoclonal antibodies in brain tumor.

Immunohistochemical analysis of the distribution of a breast tumor associated antigen recognized by a monoclonal antibody.

Suggest Documents

Bispecific monoclonal antibody regulation of Fc gamma RIII-directed tumor cytotoxicity by large granular lymphocytes.

Regulatory T cells are redirected to kill glioblastoma by an EGFRvIII-targeted bispecific antibody.

Targeted Fcγ Receptor (FcγR)-mediated Clearance by a Biparatopic Bispecific Antibody.

Reversing EGFR Mediated Immunoescape by Targeted Monoclonal Antibody Therapy.

Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.

CD3 bispecific antibody.

Enhancement of tumor uptake and therapeutic efficacy of EGFR-targeted antibody cetuximab and antibody-drug conjugates by cholesterol sequestration.

Simultaneous blockade of VEGF and Dll4 by HD105, a bispecific antibody, inhibits tumor progression and angiogenesis.

Murine monoclonal anti-idiotype antibody (alpha) as a probe to detect human monoclonal antibody bound to human tumor tissues.

Therapeutic effect of a TM4SF5-specific monoclonal antibody against colon cancer in a mouse model.

In Situ immunization by bispecific antibody targeted T cell therapy in breast cancer.

Assessment of tumor cell kinetics by monoclonal antibody Ki-67.

Biodistribution Analyses of a Near-Infrared, Fluorescently Labeled, Bispecific Monoclonal Antibody Using Optical Imaging.

Targeted therapy of solid tumors by monoclonal antibody specific to epidermal growth factor receptor.

A human hybrid hybridoma producing a bispecific monoclonal antibody that can target tumor cells for attack by Pseudomonas aeruginosa exotoxin A.

Monoclonal antibody-targeted, temperature-sensitive liposomes: in vivo tumor chemotherapeutics in combination with mild hyperthermia.

A Murine, Bispecific Monoclonal Antibody Simultaneously Recognizing β-Glucan and MP65 Determinants in Candida Species.

Inhibition of human renal cancer by monoclonal antibody targeted methotrexate-containing liposomes in an ascites tumor model.

Therapeutic evaluation of monoclonal antibody-maytansinoid conjugate as a model of RON-targeted drug delivery for pancreatic cancer treatment.

A multifunctional bispecific antibody against Pseudomonas aeruginosa as a potential therapeutic strategy.

Effect of tumor size on monoclonal antibody uptake in a metastatic model.

Affinity Maturation of Monoclonal Antibody 1E11 by Targeted Randomization in CDR3 Regions Optimizes Therapeutic Antibody Targeting of HER2-Positive Gastric Cancer.

Monitoring therapeutic monoclonal antibodies in brain tumor.

Immunohistochemical analysis of the distribution of a breast tumor associated antigen recognized by a monoclonal antibody.

Therapeutic effect of ansamitocin targeted to tumor by a bispecific monoclonal antibody.

Recommend Documents

Follow Us